Inventory & Procurement
Amino acid forward-buys, packaging consolidation, 3PL contracts
Active Decisions
4
Pending Review
2
Avg Confidence
80%
Critical / High
1
Decision Queue
4 decisions| ID | Entity | Escalation | Action | |||
|---|---|---|---|---|---|---|
DEC-IP001 | PO $1.8M Amino Acid Bulk Purchase — 6-Month Forward Buy Approve $1.8M bulk amino acid purchase. 6-month forward buy locks in 8% below spot. Risk: 18-month shelf life. | HIGH | 80% | approved | OVERDUE | |
DEC-IP002 | Packaging Vendor Consolidation — 4 to 1 Supplier Consolidate 4 bottle suppliers to single-source. Reduces MOQs and unlocks 12% volume discount on $2.4M annual spend. | MEDIUM | 84% | approved | OVERDUE | |
DEC-IP003 | 3PL Rate Renegotiation — West Coast Partner +11% West Coast 3PL raising rates 11% at renewal. Rebid against 3 competitors with current volume data. | MEDIUM | 78% | pending | OVERDUE | |
DEC-IP004 | Organ+ Reformulation — $320K Initial Production Run New SKU launch: Organ+ reformulation requires $320K initial production. 40% probability of excess inventory if launch underperforms. | MEDIUM | 76% | pending | OVERDUE |